Literature DB >> 17431933

Human exhaled air analytics: biomarkers of diseases.

Bogusław Buszewski1, Martyna Kesy, Tomasz Ligor, Anton Amann.   

Abstract

Over the last few years, breath analysis for the routine monitoring of metabolic disorders has attracted a considerable amount of scientific interest, especially since breath sampling is a non-invasive technique, totally painless and agreeable to patients. The investigation of human breath samples with various analytical methods has shown a correlation between the concentration patterns of volatile organic compounds (VOCs) and the occurrence of certain diseases. It has been demonstrated that modern analytical instruments allow the determination of many compounds found in human breath both in normal and anomalous concentrations. The composition of exhaled breath in patients with, for example, lung cancer, inflammatory lung disease, hepatic or renal dysfunction and diabetes contains valuable information. Furthermore, the detection and quantification of oxidative stress, and its monitoring during surgery based on composition of exhaled breath, have made considerable progress. This paper gives an overview of the analytical techniques used for sample collection, preconcentration and analysis of human breath composition. The diagnostic potential of different disease-marking substances in human breath for a selection of diseases and the clinical applications of breath analysis are discussed. Copyright 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17431933     DOI: 10.1002/bmc.835

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  99 in total

1.  Application of femtosecond laser mass spectrometry to the analysis of volatile organic compounds.

Authors:  Min Liu; Chengyin Wu; Zhifeng Wu; Hong Yang; Qihuang Gong; Wei Huang; Tong Zhu
Journal:  J Am Soc Mass Spectrom       Date:  2010-02-18       Impact factor: 3.109

2.  Gas-phase broadband spectroscopy using active sources: progress, status, and applications.

Authors:  Kevin C Cossel; Eleanor M Waxman; Ian A Finneran; Geoffrey A Blake; Jun Ye; Nathan R Newbury
Journal:  J Opt Soc Am B       Date:  2016-12-14       Impact factor: 2.106

3.  Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants.

Authors:  W Filipiak; V Ruzsanyi; P Mochalski; A Filipiak; A Bajtarevic; C Ager; H Denz; W Hilbe; H Jamnig; M Hackl; A Dzien; A Amann
Journal:  J Breath Res       Date:  2012-09       Impact factor: 3.262

4.  Detection of multiple sclerosis from exhaled breath using bilayers of polycyclic aromatic hydrocarbons and single-wall carbon nanotubes.

Authors:  Radu Ionescu; Yoav Broza; Hila Shaltieli; Dvir Sadeh; Yael Zilberman; Xinliang Feng; Lea Glass-Marmor; Izabella Lejbkowicz; Klaus Müllen; Ariel Miller; Hossam Haick
Journal:  ACS Chem Neurosci       Date:  2011-09-22       Impact factor: 4.418

Review 5.  Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities.

Authors:  Linda M Parsons; Akos Somoskövi; Cristina Gutierrez; Evan Lee; C N Paramasivan; Alash'le Abimiku; Steven Spector; Giorgio Roscigno; John Nkengasong
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

Review 6.  Bacterial volatiles and diagnosis of respiratory infections.

Authors:  James E Graham
Journal:  Adv Appl Microbiol       Date:  2013       Impact factor: 5.086

7.  Breathprints of childhood obesity: changes in volatile organic compounds in obese children compared with lean controls.

Authors:  N Alkhouri; K Eng; F Cikach; N Patel; C Yan; A Brindle; E Rome; I Hanouneh; D Grove; R Lopez; S L Hazen; Raed A Dweik
Journal:  Pediatr Obes       Date:  2014-03-27       Impact factor: 4.000

8.  Pyrenyl carbon nanostructures for ultrasensitive measurements of formaldehyde in urine.

Authors:  Gayan Premaratne; Sabrina Farias; Sadagopan Krishnan
Journal:  Anal Chim Acta       Date:  2017-03-27       Impact factor: 6.558

9.  Noninvasive detection of lung cancer by analysis of exhaled breath.

Authors:  Amel Bajtarevic; Clemens Ager; Martin Pienz; Martin Klieber; Konrad Schwarz; Magdalena Ligor; Tomasz Ligor; Wojciech Filipiak; Hubert Denz; Michael Fiegl; Wolfgang Hilbe; Wolfgang Weiss; Peter Lukas; Herbert Jamnig; Martin Hackl; Alfred Haidenberger; Bogusław Buszewski; Wolfram Miekisch; Jochen Schubert; Anton Amann
Journal:  BMC Cancer       Date:  2009-09-29       Impact factor: 4.430

Review 10.  Carbon monoxide in exhaled breath testing and therapeutics.

Authors:  Stefan W Ryter; Augustine M K Choi
Journal:  J Breath Res       Date:  2013-02-27       Impact factor: 3.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.